Mythocondro® is the first Non-Animal Chondroitin Sulfate (CS) obtained through a fermentation-based manufacturing process providing a reliable and reproducible source of product. Mythocondro® solves any concerns related to the production origin, the possible presence of transmissible infective agents, the contaminations and adulterations typical of animal-derived raw materials and promises to completely change the global CS industry.

Mythocondro® warrants high purity, clear identity profile, batch-to-batch reproducibility, established safety and very low content of proteins and other (macro)molecules, as well as biological activity.

Mythocondro® is clinically tested, well characterized and environmentally friendly; it is the first CS suitable for vegetarians and free from restrictions of use related to religious and supply issues.

Mythocondro® has been developed using a pharmaceutical development approach, and is the result of years of research that generated five international patents.


Mythocondro® addresses the growing demand from an aging population suffering from a variety of degenerative joint conditions that may benefit from an effective and safe nutritional supplement that supports strong and healthy joints.


Mythocondro® resolves the long-standing acknowledged problem of poor quality and potential safety issues of animal-derived CS with significant effectiveness in joint disease.

  • Produced by proprietary fermentative processes: Non-Animal production
  • High purity and quality profile guaranteed by controlled, reliable and reproducible process
  • Very low protein content and substantial absence of unusually sulfated and over-sulfated disaccharides
  • Demonstrated biological activity and established safety with published results
  • Low molecular weight and enhanced bioavailability
  • Suitable for use as an ingredient in conventional foods such as beverages and beverage bases, milk and milk products, and chewing gum